相关实验视频

Updated: Jul 9, 2025

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants

Published on: June 13, 2021

在怀孕和分娩期间参与有条件现金转账计划的体重相关结果

Ila R Falcão¹, Rita de Cássia Ribeiro-Silva^1,2, Rosemeire L Fiaccone^1,3

¹Centre for Data and Knowledge Integration for Health, Oswaldo Cruz Foundation, Salvador, Brazil.

JAMA network open

|November 28, 2023

概括

博尔萨家庭计划 (BFP) 与婴儿出生体重增加和低出生体重 (LBW) 减少有关. 这种财政支持对高风险的母亲带来了更大的好处,突出了其对母亲和儿童健康的重要性.

科学领域:

公共卫生公共卫生
孕产妇和儿童的健康
健康的社会经济决定因素

背景情况:

有条件的现金转移是减少贫困的战略,对防止不良出生结果的证据有限.
博尔萨家族计划 (BFP) 是巴西的一个重要的有条件现金转移计划.
了解BFP对出生体重指标的影响对于公共卫生政策至关重要.

研究的目的:

调查接受博尔萨家庭计划 (BFP) 福利和出生体重指标之间的关联.
分析BFP对低出生体重 (LBW) 和怀孕年龄小 (SGA) 结果的影响.
探索BFP在孕产妇教育,种族和产前护理方面的差异性影响.

主要方法:

一项大规模的队列研究,利用CIDACS出生队列 (2012-2015) 的链接出生数据.
从接受BFP至少9个月的母亲与没有接受BFP的母亲的活产的比较.
使用倾向分数匹配和加权回归分析来评估LBW,出生体重和SGA等结果.

主要成果:

BFP与出生体重 (17.76 g) 的显著增加和LBW的几率下降11%有关.
对LBW的保护作用在产前预约较少的子组,土著母亲和受教育程度较低的子组中更为明显.
总体而言,没有观察到与SGA有显著的关联,除了受教育程度较低的母亲的风险降低.

结论:

博尔萨家族计划表明,与改善出生体重和减少LBW的积极关联.
通过BFP提供的财政支持似乎对高风险的孕产妇群体特别有益.
这些发现强调了持续的财政援助计划的重要性,以减轻与出生体重相关的不良结果.

更多相关视频

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes

Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes

Published on: June 28, 2024

相关概念视频

Regression Toward the Mean

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...

Teratogenicity

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...